Results of the study and of 5 years follow up of depressed patients who participated in the study during 2014-2015. We will locate the participants and will interview them will use the same questionnaires to evaluate their depressive symptoms. We will also measure the time to relapse.
Topic Depression
Compound Ketamine
Country Israel
Visit trial
Status
Unknown status
Results Published
Start date
14 December 2019
End date
01 April 2020
Phase
Not Applicable
Design
Open
Type
Observational
Generation
First
Participants
16
Sex
All
Age
18- 99
Therapy
No
Trial Details
Anamnestic data will be collected from the patients, in addition, depressive symptoms will be measured using Montgomery Asberg Depression Scale (MADRAS). In addition, the Clinical Global Severity Scale (CGI-S) and Clinical Global Improvement (CGI-I) were performed 2 hours after treatment. In addition, we performed to prolong the time to relapse in this patient.Trial Number NCT04238039
Sponsors & Collaborators
The Chaim Sheba Medical CenterThis company doesn't have a full profile yet, it is linked to a clinical trial.